Role of adaptor protein MyD88 in TLR-mediated preconditioning and neuroprotection after acute excitotoxicity

Brain, Behavior, and Immunity

Volumn 46, Issue , 2015, Pages 221-231

  Larochelle, Antoine ^a   Bellavance, Marc André ^a   Rivest, Serge ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Excitotoxicity; Microglia; MyD88; Neuroprotection; Preconditioning; Toll like receptors

Indexed keywords

KAINIC ACID; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; LIPOPEPTIDE; PAM(3)CSK(4) PEPTIDE;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRAIN CELL; CELL DEATH; CONTROLLED STUDY; EXCITOTOXICITY; INTRASTRIATAL DRUG ADMINISTRATION; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; NERVE CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; KAINIC ACID; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NEURONS; NEUROPROTECTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84928825761     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.02.019     Document Type: Article

References (63)

1. Bellavance M.-A., Gosselin D., Yong V.W., Stys P.K., Rivest S. Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity. Brain Struct. Funct. 2014, 10.1007/s00429-014-0759-z.
2. Bernardino L., Xapelli S., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., Vezzani A., Malva J.O., Zimmer J. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci. 2005, 25:6734-6744. 10.1523/JNEUROSCI.1510-05.2005.
3. Blais V., Rivest S. Effects of TNF-alpha and IFN-gamma on nitric oxide-induced neurotoxicity in the mouse brain. J. Immunol. 2004, 172:7043-7052.
4. Block M.L., Zecca L., Hong J.-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69. 10.1038/nrn2038.
5. Bohacek I., Cordeau P., Lalancette-Hébert M., Gorup D., Weng Y.-C., Gajovic S., Kriz J. Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J. Neuroinflammation 2012, 9:191. 10.1186/1742-2094-9-191.
6. Boivin A., Pineau I., Barrette B., Filali M., Vallières N., Rivest S., Lacroix S. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J. Neurosci. 2007, 27:12565-12576. 10.1523/JNEUROSCI.3027-07.2007.
7. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 1992, 149:2736-2741.
8. Chen Z., Jalabi W., Shpargel K.B., Farabaugh K.T., Dutta R., Yin X., Kidd G.J., Bergmann C.C., Stohlman S.A., Trapp B.D. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J. Neurosci. 2012, 32:11706-11715. 10.1523/JNEUROSCI.0730-12.2012.
9. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994, 12:139-153.
10. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.-B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758. 10.1038/nn1472.
11. Deacon R.M.J. Assessing nest building in mice. Nat. Protoc. 2006, 1:1117-1119. 10.1038/nprot.2006.170.
12. Dmowska M., Cybulska R., Schoenborn R., Piersiak T., Jaworska-Adamu J., Gawron A. Behavioural and histological effects of preconditioning with lipopolysaccharide in epileptic rats. Neurochem. Res. 2010, 35:262-272. 10.1007/s11064-009-0050-5.
13. Downes C.E., Wong C.H.Y., Henley K.J., Guio-Aguilar P.L., Zhang M., Ates R., Mansell A., Kile B.T., Crack P.J. MyD88 is a critical regulator of hematopoietic cell-mediated neuroprotection seen after stroke. PLoS One 2013, 8:e57948. 10.1371/journal.pone.0057948.
14. Drouin-Ouellet J., LeBel M., Filali M., Cicchetti F. MyD88 deficiency results in both cognitive and motor impairments in mice. Brain Behav. Immun. 2012, 26:880-885. 10.1016/j.bbi.2012.02.007.
15. Famakin B.M., Mou Y., Ruetzler C.A., Bembry J., Maric D., Hallenbeck J.M. Disruption of downstream MyD88 or TRIF Toll-like receptor signaling does not protect against cerebral ischemia. Brain Res. 2011, 1388:148-156. 10.1016/j.brainres.2011.02.074.
16. Figiel I. Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol. Exp. (Wars) 2008, 68:526-534.
17. Garcia J.H., Wagner S., Liu K.F., Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995, 26:627-634. discussion 635.
18. Gosselin D., Bellavance M.-A., Rivest S. IL-1RAcPb signaling regulates adaptive mechanisms in neurons that promote their long-term survival following excitotoxic insults. Front. Cell Neurosci. 2013, 7:9. 10.3389/fncel.2013.00009.
19. Hao H.P., Doh-Ura K., Nakanishi H. Impairment of microglial responses to facial nerve axotomy in cathepsin S-deficient mice. J. Neurosci. Res. 2007, 85:2196-2206. 10.1002/jnr.21357.
20. Hong J., Cho I.H., Kwak K.I., Suh E.C., Seo J., Min H.J., Choi S.Y., Kim C.H., Park S.H., Jo E.K., Lee S., Lee K.E., Lee S.J. Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J. Biol. Chem. 2010, 285:39447-39457. 10.1074/jbc.M110.132522.
21. Hua F., Ma J., Ha T., Xia Y., Kelley J., Williams D.L., Kao R.L., Browder I.W., Schweitzer J.B., Kalbfleisch J.H., Li C. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 2007, 190:101-111. 10.1016/j.jneuroim.2007.08.014.
22. Hua F., Ma J., Ha T., Kelley J., Williams D.L., Kao R.L., Kalbfleisch J.H., Browder I.W., Li C. Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J. Neuroimmunol. 2008, 199:75-82. 10.1016/j.jneuroim.2008.05.009.
23. Ito D., Tanaka K., Suzuki S., Dembo T., Fukuuchi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 2001, 32:1208-1215.
24. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11:115-122.
25. Kigerl K.A., Lai W., Rivest S., Hart R.P., Satoskar A.R., Popovich P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 2007, 102:37-50. 10.1111/j.1471-4159.2007.04524.x.
26. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J. Neurochem. 1999, 73:309-321.
27. Laflamme N., Echchannaoui H., Landmann R., Rivest S. Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur. J. Immunol. 2003, 33:1127-1138. 10.1002/eji.200323821.
28. Lalancette-Hébert M., Gowing G., Simard A., Weng Y.-C., Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 2007, 27:2596-2605. 10.1523/JNEUROSCI.5360-06.2007.
29. Lalancette-Hébert M., Phaneuf D., Soucy G., Weng Y.C., Kriz J. Live imaging of Toll-like receptor 2 response in cerebral ischaemia reveals a role of olfactory bulb microglia as modulators of inflammation. Brain 2009, 132:940-954. 10.1093/brain/awn345.
30. Lambertsen K.L., Clausen B.H., Babcock A.A., Gregersen R., Fenger C., Nielsen H.H., Haugaard L.S., Wirenfeldt M., Nielsen M., Dagnaes-Hansen F., Bluethmann H., Faergeman N.J., Meldgaard M., Deierborg T., Finsen B. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 2009, 29:1319-1330. 10.1523/JNEUROSCI.5505-08.2009.
31. Lampron A., Lessard M., Rivest S. Effects of myeloablation, peripheral chimerism, and whole-body irradiation on the entry of bone marrow-derived cells into the brain. Cell Transplant. 2012, 21:1149-1159. 10.3727/096368911X593154.
32. Lehnardt S., Lehmann S., Kaul D., Tschimmel K., Hoffmann O., Cho S., Krueger C., Nitsch R., Meisel A., Weber J.R. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 2007, 190:28-33. 10.1016/j.jneuroim.2007.07.023.
33. Leung P.Y., Stevens S.L., Packard A.E.B., Lessov N.S., Yang T., Conrad V.K., van den Dungen N.N.A.M., Simon R.P., Stenzel-Poore M.P. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke 2012, 43:1383-1389. 10.1161/STROKEAHA.111.641522.
34. Longhi L., Gesuete R., Perego C., Ortolano F., Sacchi N., Villa P., Stocchetti N., De Simoni M.-G. Long-lasting protection in brain trauma by endotoxin preconditioning. J. Cereb. Blood Flow Metab. 2011, 31:1919-1929. 10.1038/jcbfm.2011.42.
35. Mallard C. Innate immune regulation by Toll-like receptors in the brain. ISRN Neurol. 2012, 2012:1-19. 10.1016/j.nbd.2011.07.011.
36. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2010, 16:413-419. 10.1038/nm.2127.
37. Marsh B.J., Williams-Karnesky R.L., Stenzel-Poore M.P. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 2009, 158:1007-1020. 10.1016/j.neuroscience.2008.07.067.
38. Mattson M.P. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol. Med. 2003, 3:65-94. 10.1385/NMM:3:2:65.
39. Michaud J.-P., Bellavance M.-A., Préfontaine P., Rivest S. Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep. 2013, 5:646-653. 10.1016/j.celrep.2013.10.010.
40. Mirrione M.M., Konomos D.K., Gravanis I., Dewey S.L., Aguzzi A., Heppner F.L., Tsirka S.E. Neurobiology of disease. Neurobiol. Dis. 2010, 39:85-97. 10.1016/j.nbd.2010.04.001.
41. Nadeau S., Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J. Neurosci. 2000, 20:3456-3468.
42. Neumann H., Kotter M.R., Franklin R.J.M. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288-295. 10.1093/brain/awn109.
43. Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011, 34:269-281. 10.1016/j.tins.2011.02.005.
44. Packard A.E.B., Hedges J.C., Bahjat F.R., Stevens S.L., Conlin M.J., Salazar A.M., Stenzel-Poore M.P. Poly-IC preconditioning protects against cerebral and renal ischemia-reperfusion injury. J. Cereb. Blood Flow Metab. 2012, 32:242-247. 10.1038/jcbfm.2011.160.
45. Packard A.E.B., Leung P.Y., Vartanian K.B., Stevens S.L., Bahjat F.R., Stenzel-Poore M.P. TLR9 bone marrow chimeric mice define a role for cerebral TNF in neuroprotection induced by CpG preconditioning. J. Cereb. Blood Flow Metab. 2012, 32:2193-2200. 10.1038/jcbfm.2012.140.
46. Pimentel-Coelho P.M., Michaud J.-P., Rivest S. Evidence for a gender-specific protective role of innate immune receptors in a model of perinatal brain injury. J. Neurosci. 2013, 33:11556-11572. 10.1523/JNEUROSCI.0535-13.2013.
47. Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9:429-439. 10.1038/nri2565.
48. Rosenzweig H.L., Lessov N.S., Henshall D.C., Minami M., Simon R.P., Stenzel-Poore M.P. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 2004, 35:2576-2581. 10.1161/01.STR.0000143450.04438.ae.
49. Saha R.N., Ghosh A., Palencia C.A., Fung Y.K., Dudek S.M., Pahan K. TNF-preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein. J. Immunol. 2009, 183:2068-2078. 10.4049/jimmunol.0801892.
50. Shaked I., Tchoresh D., Gersner R., Meiri G., Mordechai S., Xiao X., Hart R.P., Schwartz M. Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J. Neurochem. 2005, 92:997-1009. 10.1111/j.1471-4159.2004.02954.x.
51. Simard A.R., Rivest S. Neuroprotective effects of resident microglia following acute brain injury. J. Comp. Neurol. 2007, 504:716-729. 10.1002/cne.21469.
52. Stevens S.L., Ciesielski T.M.P., Marsh B.J., Yang T., Homen D.S., Boule J.-L., Lessov N.S., Simon R.P., Stenzel-Poore M.P. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 2008, 28:1040-1047. 10.1038/sj.jcbfm.9600606.
53. Stirling D.P., Cummins K., Mishra M., Teo W., Yong V.W., Stys P. Toll-like receptor 2-mediated alternative activation of microglia is protective after spinal cord injury. Brain 2013, 137:707-723. 10.1093/brain/awt341.
54. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820. 10.1016/j.cell.2010.01.022.
55. Tasaki K., Ruetzler C.A., Ohtsuki T., Martin D., Nawashiro H., Hallenbeck J.M. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 1997, 748:267-270.
56. Turrin N.P. Tumor necrosis factor but not interleukin 1 mediates neuroprotection in response to acute nitric oxide excitotoxicity. J. Neurosci. 2006, 26:143-151. 10.1523/JNEUROSCI.4032-05.2006.
57. Ulmann L., Levavasseur F., Avignone E., Peyroutou R., Hirbec H., Audinat E., Rassendren F. Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus. Glia 2013, 1306-1319. 10.1002/glia.22516.
58. Vartanian K.B., Stevens S.L., Marsh B.J., Williams-Karnesky R., Lessov N.S., Stenzel-Poore M.P. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J. Neuroinflammation 2011, 8:140. 10.1186/1742-2094-8-140.
59. Wang Q., Yu S., Simonyi A., Sun G.Y., Sun A.Y. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol. Neurobiol. 2005, 31:3-16. 10.1385/MN:31:1-3:003.
60. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003, 301:640-643. 10.1126/science.1087262.
61. Yang Q.-W., Li J.-C., Lu F.-L., Wen A.-Q., Xiang J., Zhang L.-L., Huang Z.-Y., Wang J.-Z. Upregulated expression of Toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J. Cereb. Blood Flow Metab. 2008, 28:1588-1596. 10.1038/jcbfm.2008.50.
62. Zhang X.-M., Zhu J. Kainic acid-induced neurotoxicity: targeting glial responses and glia-derived cytokines. Curr. Neuropharmacol. 2011, 9:388-398. 10.2174/157015911795596540.
63. Zhu W., Zheng H., Shao X., Wang W., Yao Q., Li Z. Excitotoxicity of TNFalpha derived from KA activated microglia on hippocampal neurons in vitro and in vivo. J. Neurochem. 2010, 114:386-396. 10.1111/j.1471-4159.2010.06763.x.